Downgrades by analysts, especially with a significant price target reduction, typically lead to negative investor sentiment and can result in a short-term decline in the stock price. The direct mention of IGM Biosciences and the specific details of the downgrade suggest a high relevance and importance to the company's stock. The confidence level is high due to the clear and direct impact analyst ratings have on stock performance, particularly in the short term.